Structures by: Caballero A. B.
Total: 62
(C24H30Cl2Cu2N6O11),(CH4O)
(C24H30Cl2Cu2N6O11),(CH4O)
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=11.893(9)Å b=21.582(9)Å c=12.732(5)Å
α=90.00° β=92.466(9)° γ=90.00°
C16H18ClCuN3O,CH4O
C16H18ClCuN3O,CH4O
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=7.9513(4)Å b=10.1551(5)Å c=11.4377(5)Å
α=103.3680(10)° β=96.2100(10)° γ=100.2460(10)°
C31H32ClCu2N6O7,ClO4
C31H32ClCu2N6O7,ClO4
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=7.629(3)Å b=13.448(4)Å c=17.723(5)Å
α=110.693(4)° β=97.801(4)° γ=94.246(4)°
C80H76Cl6Cu3N12O4,6(CH4O)
C80H76Cl6Cu3N12O4,6(CH4O)
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=10.9272(10)Å b=11.8160(11)Å c=18.887(2)Å
α=73.7590(10)° β=81.8970(10)° γ=72.6210(10)°
(C88H84Cu8N28O21),3(NO3),(CH3O),0.5(O2),7(O)
(C88H84Cu8N28O21),3(NO3),(CH3O),0.5(O2),7(O)
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=15.8661(5)Å b=15.9224(5)Å c=26.4434(9)Å
α=76.0760(10)° β=87.3960(10)° γ=68.3660(10)°
C20H20CuN4O4
C20H20CuN4O4
Metallomics : integrated biometal science (2014) 6, 10 1853-1868
a=17.2957(12)Å b=6.6675(5)Å c=18.3318(9)Å
α=90.00° β=119.727(5)° γ=90.00°
C34H26Cu2N204,4(ClO41)
C34H26Cu2N204,4(ClO41)
Polyhedron (2012) 33, 137-144
a=12.2871(8)Å b=13.2034(8)Å c=14.4520(9)Å
α=90.00° β=101.1210(10)° γ=90.00°
C21H18CdCl2N12O9
C21H18CdCl2N12O9
Polyhedron (2012) 33, 137-144
a=11.287(5)Å b=11.326(5)Å c=13.021(5)Å
α=72.606(5)° β=81.428(5)° γ=62.597(5)°
C22H26CuN12O22,2(ClO41),H2O
C22H26CuN12O22,2(ClO41),H2O
Polyhedron (2012) 33, 137-144
a=12.2331(7)Å b=18.6877(11)Å c=14.1421(8)Å
α=90.00° β=99.015(1)° γ=90.00°
C38H44Cl4N34O20Zn2
C38H44Cl4N34O20Zn2
Polyhedron (2012) 33, 137-144
a=10.749(5)Å b=12.668(5)Å c=13.623(5)Å
α=68.880(5)° β=69.730(5)° γ=66.269(5)°
C44H48Cd2Cl4N24O18
C44H48Cd2Cl4N24O18
Polyhedron (2012) 33, 137-144
a=15.3067(11)Å b=17.7804(12)Å c=22.6353(16)Å
α=90.00° β=90.00° γ=90.00°
C18H30N12NiO2
C18H30N12NiO2
Inorganica Chimica Acta (2011) 378, 194-201
a=8.841(5)Å b=8.667(5)Å c=16.086(5)Å
α=90.00° β=110.00(2)° γ=90.00°
C20H36CuN122,2(ClO41)
C20H36CuN122,2(ClO41)
Inorganica Chimica Acta (2011) 378, 194-201
a=8.0816(5)Å b=8.2729(5)Å c=12.4711(8)Å
α=94.457(1)° β=99.007(1)° γ=111.190(1)°
C18H30N12NiO2
C18H30N12NiO2
Inorganica Chimica Acta (2011) 378, 194-201
a=9.1952(6)Å b=10.0364(6)Å c=13.0833(8)Å
α=78.240(1)° β=75.027(1)° γ=77.782(1)°
C16H28N14Zn2,2(ClO4)
C16H28N14Zn2,2(ClO4)
Inorganica Chimica Acta (2011) 378, 194-201
a=9.018(5)Å b=12.357(5)Å c=13.105(5)Å
α=68.762(5)° β=88.860(5)° γ=88.401(5)°
C12H25CuN8O1,ClO41,0.5(H2O)
C12H25CuN8O1,ClO41,0.5(H2O)
Inorganica Chimica Acta (2011) 378, 194-201
a=14.9583(9)Å b=19.8392(12)Å c=14.5068(9)Å
α=90.00° β=107.401(1)° γ=90.00°
C5H4CdN10
C5H4CdN10
CrystEngComm (2010) 12, 3038-3045
a=3.6149(2)Å b=11.4499(7)Å c=12.1649(8)Å
α=70.789(1)° β=82.385(1)° γ=86.674(1)°
C7H4CdN6O2
C7H4CdN6O2
CrystEngComm (2010) 12, 3038-3045
a=3.5617(4)Å b=11.4103(13)Å c=12.0524(14)Å
α=71.286(2)° β=83.404(2)° γ=87.609(2)°
C12H8CdN10S2
C12H8CdN10S2
CrystEngComm (2010) 12, 3038-3045
a=8.3799(19)Å b=19.526(4)Å c=10.357(2)Å
α=90.00° β=90.00° γ=90.00°
C24H20Co2N20O2S4
C24H20Co2N20O2S4
CrystEngComm (2010) 12, 3038-3045
a=12.510(3)Å b=12.902(3)Å c=12.175(3)Å
α=90.00° β=116.431(3)° γ=90.00°
C12H12MnN10O2S2
C12H12MnN10O2S2
CrystEngComm (2010) 12, 3038-3045
a=8.6882(7)Å b=12.6477(10)Å c=9.0639(7)Å
α=90.00° β=111.7360(10)° γ=90.00°
C24H20N20Ni2O2S4
C24H20N20Ni2O2S4
CrystEngComm (2010) 12, 3038-3045
a=12.3178(8)Å b=12.8907(8)Å c=12.1015(8)Å
α=90.00° β=115.818(1)° γ=90.00°
C12H8N10S2Zn
C12H8N10S2Zn
CrystEngComm (2010) 12, 3038-3045
a=8.3561(8)Å b=9.8609(9)Å c=11.2066(10)Å
α=86.6056(14)° β=71.8330(13)° γ=71.3906(13)°
C12H8N10O2Zn
C12H8N10O2Zn
CrystEngComm (2010) 12, 3038-3045
a=11.918(5)Å b=11.340(5)Å c=12.434(5)Å
α=90.000(5)° β=115.472(5)° γ=90.000(5)°
Compound_7
C32H52Cl4Cu2N12O16S4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 22 7551-7560
a=7.1811(3)Å b=26.8955(13)Å c=13.1818(7)Å
α=90° β=97.643(5)° γ=90°
Compound_3
C16H26CoN8O14S2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 22 7551-7560
a=20.903(4)Å b=6.522(2)Å c=21.396(10)Å
α=90° β=113.45(2)° γ=90°
Compound_13
C16H26N8O14S2Zn
Dalton transactions (Cambridge, England : 2003) (2018) 47, 22 7551-7560
a=20.7776(11)Å b=6.5108(4)Å c=21.3007(11)Å
α=90° β=114.0800(10)° γ=90°
Compound_9
C8H13Cu0.50N4O7S
Dalton transactions (Cambridge, England : 2003) (2018) 47, 22 7551-7560
a=7.2258(5)Å b=10.8229(8)Å c=16.4296(12)Å
α=90° β=90.376(5)° γ=90°
C26H24Cl4Cu2N4
C26H24Cl4Cu2N4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4902-4908
a=8.1238(5)Å b=8.7699(5)Å c=10.6962(6)Å
α=78.201(5)° β=72.412(5)° γ=66.904(5)°
C6H15Cl2CoN4O14
C6H15Cl2CoN4O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=12.923(5)Å b=6.542(5)Å c=10.446(5)Å
α=90.00° β=90.00° γ=90.00°
C24H28Cl2CuN16O14
C24H28Cl2CuN16O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=11.752(2)Å b=11.663(2)Å c=12.921(2)Å
α=90.00° β=101.396(2)° γ=90.00°
C12H20Cl2CuN8O14
C12H20Cl2CuN8O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=14.166(5)Å b=13.435(5)Å c=13.405(5)Å
α=90.00° β=102.357(5)° γ=90.00°
C8H13CuN5O7
C8H13CuN5O7
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=6.927(5)Å b=7.603(5)Å c=13.009(5)Å
α=87.030(5)° β=81.785(5)° γ=71.481(5)°
C5H5N5
C5H5N5
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=3.7456(4)Å b=11.8913(12)Å c=13.0276(13)Å
α=90.00° β=97.8090(10)° γ=90.00°
C20H30Cl4Cu2N20O21
C20H30Cl4Cu2N20O21
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=18.291(3)Å b=18.838(3)Å c=12.285(2)Å
α=90.00° β=90.610(3)° γ=90.00°
C12H10CuN10O4,3(H2O)
C12H10CuN10O4,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=25.0574(10)Å b=6.8244(3)Å c=24.2133(9)Å
α=90.00° β=116.800(5)° γ=90.00°
C14H18CuN10O6
C14H18CuN10O6
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=7.2299(8)Å b=11.3987(12)Å c=12.7792(12)Å
α=90.00° β=117.793(5)° γ=90.00°
(tetrakisacetonitrile-bis(mu-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) bis(tetrafluoroborate)
C18H20Ag2N12,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=6.2201(2)Å b=10.6272(2)Å c=11.5588(8)Å
α=110.016(8)° β=99.817(7)° γ=91.442(6)°
(tetrakisacetonitrile-bis(mu-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) bis(perchlorate)
C18H20Ag2N12,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=6.32530(10)Å b=10.7545(2)Å c=11.5478(8)Å
α=110.093(8)° β=100.489(7)° γ=90.426(6)°
(bis(mu-7-amine-1,2,4-triazolo(1,5-a)pyrimidine)disilver(i)) bis(perchlorate)
C10H10Ag2N10,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=5.7889(15)Å b=8.389(2)Å c=10.138(3)Å
α=109.414(3)° β=91.774(3)° γ=102.566(3)°
(acetonitrile-bis(mu-5,7-dimethyl-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) tetrafluoroborate perchlorate
C16H19Ag2N9,F6P,ClO4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=11.228(5)Å b=11.471(5)Å c=12.191(5)Å
α=110.932(5)° β=112.874(5)° γ=97.284(5)°
(bis(mu-trifluoromethylsulfonate)-bis(mu-5,7-dimethyl-1,2,4- triazolo(1,5-a)pyrimidine)disilver(i))
C8H8AgF3N4O3S
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=8.3689(2)Å b=8.6550(2)Å c=9.0743(6)Å
α=93.984(7)° β=94.541(7)° γ=112.430(8)°
Catena-(bis(mu-1,2,4-triazolo(1,5-a)pyrimidine)disilver(i)) bis(hexafluorophosphate) hexahydrate
C5H4AgN4O0.12,F6P
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=26.0272(3)Å b=26.0272(3)Å c=11.0746(2)Å
α=90.00° β=90.00° γ=120.00°
C40H38Cl2N8O11S4Zn
C40H38Cl2N8O11S4Zn
CrystEngComm (2014) 16, 36 8322
a=16.529(2)Å b=16.529(2)Å c=16.604(2)Å
α=90.00° β=90.00° γ=90.00°
C42H32MnN10S6
C42H32MnN10S6
CrystEngComm (2014) 16, 36 8322
a=9.694(3)Å b=11.143(4)Å c=11.326(3)Å
α=87.71(4)° β=76.90(3)° γ=67.65(4)°
C12H8N4O2SZn
C12H8N4O2SZn
CrystEngComm (2014) 16, 36 8322
a=14.545(3)Å b=14.834(3)Å c=12.805(4)Å
α=90° β=90° γ=90°
C22H16FeN6S4,2(H2O)
C22H16FeN6S4,2(H2O)
CrystEngComm (2014) 16, 36 8322
a=17.001(6)Å b=10.288(4)Å c=16.629(6)Å
α=90° β=118.53(4)° γ=90°
C40H38Cl2N8O11S4Zn
C40H38Cl2N8O11S4Zn
CrystEngComm (2014) 16, 36 8322
a=16.529(2)Å b=16.529(2)Å c=16.604(2)Å
α=90.00° β=90.00° γ=90.00°
C42H32MnN10S6
C42H32MnN10S6
CrystEngComm (2014) 16, 36 8322
a=9.694(3)Å b=11.143(4)Å c=11.326(3)Å
α=87.71(4)° β=76.90(3)° γ=67.65(4)°
C12H8N4O2SZn
C12H8N4O2SZn
CrystEngComm (2014) 16, 36 8322
a=14.545(3)Å b=14.834(3)Å c=12.805(4)Å
α=90° β=90° γ=90°
C22H16FeN6S4,2(H2O)
C22H16FeN6S4,2(H2O)
CrystEngComm (2014) 16, 36 8322
a=17.001(6)Å b=10.288(4)Å c=16.629(6)Å
α=90° β=118.53(4)° γ=90°
C15H12ClCuN5O7
C15H12ClCuN5O7
Dalton transactions (Cambridge, England : 2003) (2015) 44, 36 16061-16072
a=8.684(2)Å b=19.023(5)Å c=10.487(3)Å
α=90.00° β=96.817(3)° γ=90.00°
C26H21CuN4O5,NO3,CH4O
C26H21CuN4O5,NO3,CH4O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 36 16061-16072
a=7.2118(9)Å b=19.471(2)Å c=37.885(5)Å
α=90° β=91.302(2)° γ=90°
4,7-Phenanthrolinium perchlorate--5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one-- water (1/1/2)
C12H9N2,ClO4,C6H6N4O,2(H2O)
Acta Crystallographica Section E (2010) 66, 2 o459-o460
a=8.6082(8)Å b=14.7723(14)Å c=16.8079(17)Å
α=90.00° β=104.609(2)° γ=90.00°
Bis(cyanato-κ<i>N</i>)bis(5,7-dimethyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine- κ<i>N</i>^3^)zinc
C16H16N10O2Zn
Acta Crystallographica Section E (2011) 67, 3 m345
a=10.0023(15)Å b=10.8168(16)Å c=11.1094(16)Å
α=116.772(2)° β=107.226(2)° γ=98.557(2)°
Bis(7-amino-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-4-ium) bis(oxalato-κ^2^<i>O</i>^1^,<i>O</i>^2^)cuprate(II) dihydrate
2(C5H6N5),C4CuO82,2(H2O)
Acta Crystallographica Section E (2011) 67, 11 m1531-m1532
a=3.6599(2)Å b=24.1977(10)Å c=11.1963(5)Å
α=90.00° β=92.344(4)° γ=90.00°
C26H19N3O
C26H19N3O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 36 16061-16072
a=5.9083(15)Å b=8.824(2)Å c=18.775(5)Å
α=90.00° β=96.643(18)° γ=90.00°
C14H24MnN8O42,2(C7H8N4),2(ClO41),2(H2O)
C14H24MnN8O42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.9135(8)Å b=8.5203(5)Å c=17.7690(10)Å
α=90.00° β=111.617(1)° γ=90.00°
C14H24FeN8O42,2(C7H8N4),2(ClO41),2(H2O)
C14H24FeN8O42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.8776(11)Å b=8.5567(6)Å c=17.6690(13)Å
α=90.00° β=111.748(1)° γ=90.00°
C14H24N8NiO42,2(C7H8N4),2(ClO41),2(H2O)
C14H24N8NiO42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.8078(8)Å b=8.6073(5)Å c=17.5587(10)Å
α=90.00° β=112.121(1)° γ=90.00°
C28H36CuN16O22,2(ClO41),2(H2O)
C28H36CuN16O22,2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=8.6399(9)Å b=11.9756(12)Å c=19.1916(18)Å
α=90.00° β=90.352(1)° γ=90.00°
C14H24N8O4Zn2,2(C7H8N4),2(ClO41),2(H2O)
C14H24N8O4Zn2,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.830(2)Å b=8.5741(12)Å c=17.618(2)Å
α=90.00° β=111.980(2)° γ=90.00°